Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
ESR1311G Coxiella burnetii IgG Phase I QED 96tests 557.55 ESR1311G Coxiella burnetii IgG Phase I QED 96tests 557.55 Publication
ESR1312G Coxiella burnetii IgG Phase II QED 96tests 557.55 ESR1312G Coxiella burnetii IgG Phase II QED 96tests 557.55 Publication
IPLA-ADPF-SER-1ml Single Donor Human Atopic Dermatitis Serum 1ml Innovative Research INC 401 IPLA-ADPF-SER-1ml Single Donor Human Atopic Dermatitis Serum 1ml Innovative Research INC 401
ASK
Publication
IPLA-ADPF-1ml Single Donor Human Atopic Dermatitis Plasma 1ml Innovative Research INC 1ml 513 IPLA-ADPF-1ml Single Donor Human Atopic Dermatitis Plasma 1ml Innovative Research INC 1ml 513
ASK
Publication
MD-14-0524 Rabbit Anti-Human S-phase Kinase-associated Protein 1A (SKP1) Antibodies Ray Biotech 100 650 MD-14-0524 Rabbit Anti-Human S-phase Kinase-associated Protein 1A (SKP1) Antibodies Ray Biotech 100 650
ASK
Publication
IPLA-ADPF Disease State Samples: Single Donor Human Atopic Dermatitis Plasma Innovative Research INC 1ml 342 IPLA-ADPF Disease State Samples: Single Donor Human Atopic Dermatitis Plasma Innovative Research INC 1ml 342
ASK
Publication
ABI500 Enzyme Label Diluent Scy tek 500 ml 93 ABI500 Enzyme Label Diluent Scy tek 500 ml 93
ASK
Publication
ABI999 Enzyme Label Diluent Scy tek 1000 ml 112 ABI999 Enzyme Label Diluent Scy tek 1000 ml 112
ASK
Publication
4828-30-BC TACS Blue Label Detection Module Trevigen 30 Samples 118 4828-30-BC TACS Blue Label Detection Module Trevigen 30 Samples 118
ASK
Publication
MAB-100-IL17A Monoclonal antibody: Human IL-17A; Label: Unlabeled; Source,isotype: Mouse IgG2b k; Clone: 4H1524 Shenandoah Biotechnology, Inc. 100ug 270 MAB-100-IL17A Monoclonal antibody: Human IL-17A; Label: Unlabeled; Source,isotype: Mouse IgG2b k; Clone: 4H1524 Shenandoah Biotechnology, Inc. 100ug 270
ASK
Publication
M0851 7 (Diethylamino)coumarin 3 carboxylic acid, Blue green fluorescent label for use in peptide and protein modification, 100mg MarkerGene 134 M0851 7 (Diethylamino)coumarin 3 carboxylic acid, Blue green fluorescent label for use in peptide and protein modification, 100mg MarkerGene 134
ASK
Publication
M0972 MarkerGeneTM TAMRA Antibody Protein Cell Labeling Kit, Provides reagents and methods to simply and quickly label antibodies or other proteins with the amine reactive dye 5(6) carboxytetramethylrhodami MarkerGene 299 M0972 MarkerGeneTM TAMRA Antibody Protein Cell Labeling Kit, Provides reagents and methods to simply and quickly label antibodies or other proteins with the amine reactive dye 5(6) carboxytetramethylrhodami MarkerGene 299
ASK
Publication
AXL764TC CD3 (Clone UCHT1), RPE Cy5 + CD8 (Clone DK25), FITC + CD4 (Clone MT310), RPE, Mab anti , tri label Accurate 0.5 ml. 1 AXL764TC CD3 (Clone UCHT1), RPE Cy5 + CD8 (Clone DK25), FITC + CD4 (Clone MT310), RPE, Mab anti , tri label Accurate 0.5 ml. 1
ASK
Publication
M1622 OliGloTM Cy3 FISH Kit trial size MarkerGene 374 M1622 OliGloTM Cy3 FISH Kit trial size MarkerGene 374
ASK
Publication
STPT Stabil PAC Trial (1 x 10 mg Nvoy Polymer) Expedeon 89.25 STPT Stabil PAC Trial (1 x 10 mg Nvoy Polymer) Expedeon 89.25
ASK
Publication
M1624 OliGloTM Biotin FISH Kit trial size MarkerGene 374 M1624 OliGloTM Biotin FISH Kit trial size MarkerGene 374
ASK
Publication
30029-T NUC VIEW 488 CASPASE 3 ASSAY KIT, TRIAL SIZE Biotium 1 ST 174.216 30029-T NUC VIEW 488 CASPASE 3 ASSAY KIT, TRIAL SIZE Biotium 1 ST 174.216
ASK
Publication
HTK-05 Hemo Trial Kit™ Biotech support group 5 ml Hemoglobind ,5 Preps of Hemovoid 355 HTK-05 Hemo Trial Kit™ Biotech support group 5 ml Hemoglobind ,5 Preps of Hemovoid 355 Publication
M1620 OliGloTM TAMRA FISH Kit trial size MarkerGene 374 M1620 OliGloTM TAMRA FISH Kit trial size MarkerGene 374
ASK
Publication
M1602 OliGloTM Cy3 Universal Nucleic Acid Labeling Kit trial size MarkerGene 281 M1602 OliGloTM Cy3 Universal Nucleic Acid Labeling Kit trial size MarkerGene 281
ASK
Publication
KOG-200TE New 8 OHdG Check ELISA Trial Package (32wells) JaICA 32 wells 439 KOG-200TE New 8 OHdG Check ELISA Trial Package (32wells) JaICA 32 wells 439
ASK
Publication
M1604 OliGloTM Biotin Universal Nucleic Acid Labeling Kit trial size MarkerGene 281 M1604 OliGloTM Biotin Universal Nucleic Acid Labeling Kit trial size MarkerGene 281
ASK
Publication
41005-T GelGreen Nucleic Acid Stain, 10,000X in water (trial size) Biotium 0,1 ML 81.9 41005-T GelGreen Nucleic Acid Stain, 10,000X in water (trial size) Biotium 0,1 ML 81.9
ASK
Publication
M1600 OliGloTM TAMRA Universal Nucleic Acid Labeling Kit trial size MarkerGene 281 M1600 OliGloTM TAMRA Universal Nucleic Acid Labeling Kit trial size MarkerGene 281
ASK
Publication
41003-T GelRed Nucleic Acid Stain, 10,000X in water (trial size) Biotium 0,1 ML 85 41003-T GelRed Nucleic Acid Stain, 10,000X in water (trial size) Biotium 0,1 ML 85
ASK
Publication
BR701 Breast cancer tissue array, 70 cases 70 cores, with TNM data plus ER, PR and Her 2 (C erbB 2, neu< em>) IHC results, replaced by BR962 US Biomax 231 BR701 Breast cancer tissue array, 70 cases 70 cores, with TNM data plus ER, PR and Her 2 (C erbB 2, neu< em>) IHC results, replaced by BR962 US Biomax 231
ASK
Publication
BR1503 Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 US Biomax 278 BR1503 Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 US Biomax 278
ASK
Publication
BR1502 Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503 US Biomax 278 BR1502 Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503 US Biomax 278
ASK
Publication
PM2-ER ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed US Biomax 114 PM2-ER ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed US Biomax 114
ASK
Publication
BRC961 Breast cancer array with normal and other non malignant breast tissues, non overlapping with BRC962, with AR ER PR Her 2(neu) IHC results, 48 cases 96 cores US Biomax 225 BRC961 Breast cancer array with normal and other non malignant breast tissues, non overlapping with BRC962, with AR ER PR Her 2(neu) IHC results, 48 cases 96 cores US Biomax 225
ASK
Publication
BR961 Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replaced by BR962 US Biomax 0 BR961 Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replaced by BR962 US Biomax 0
ASK
Publication
BR962 Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701 US Biomax 231 BR962 Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701 US Biomax 231
ASK
Publication
BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme US Biomax 296 BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme US Biomax 296
ASK
Publication
BR451 Breast cancer tissue microarray with matched normal adjacent tissue and metastatic lymph nodes, 45cases 45 cores, with ER, PR and P53 IHC results US Biomax 160 BR451 Breast cancer tissue microarray with matched normal adjacent tissue and metastatic lymph nodes, 45cases 45 cores, with ER, PR and P53 IHC results US Biomax 160
ASK
Publication
BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin US Biomax 296 BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin US Biomax 296
ASK
Publication
BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores US Biomax 456 BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores US Biomax 456
ASK
Publication
BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 US Biomax 456 BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 US Biomax 456
ASK
Publication
BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 US Biomax 456 BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 US Biomax 456
ASK
Publication
BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc US Biomax 429 BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc US Biomax 429
ASK
Publication
BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- US Biomax 296 BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- US Biomax 296
ASK
Publication
  Cat_Number Product name Supplier Quantity Price Tech More